-transparent.png){kind=logo}
Pheochromocytoma (PCC)/paraganglioma is a catecholamine-secreting tumor of the paraganglion. The hereditary variants of PCC have been previously considered to occur in 10% of cases. The latest researches have clearly demonstrated that the hereditary cause of chromaffin tumors is revealed in a much larger number of patients. There have been the most investigated NF, RET, VHL, SDHD, SDHC, and SDHB gene mutations. New EGLN1/PHD2, KIF1В, SDH5/SDHAF2, IDH1, TMEM127, SDHA, MAX, and HIF2А gene mutations have been recently discovered. This review describes the most common PCC-associated syndromes in detail and considers the specific features of new mutations.
| UI | MeSH Term | Description | Entries |
|---|
Related Publications
M Yu Yukina, and
E A Troshina, and
D G Beltsevich
October 2014,
Head & neck,
M Yu Yukina, and
E A Troshina, and
D G Beltsevich
May 2012,
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
M Yu Yukina, and
E A Troshina, and
D G Beltsevich
January 2022,
Endocrine oncology (Bristol, England),
M Yu Yukina, and
E A Troshina, and
D G Beltsevich
June 2019,
Mayo Clinic proceedings,
M Yu Yukina, and
E A Troshina, and
D G Beltsevich
June 2005,
Annales d'endocrinologie,
M Yu Yukina, and
E A Troshina, and
D G Beltsevich
January 2014,
Case reports in endocrinology,
M Yu Yukina, and
E A Troshina, and
D G Beltsevich
January 2008,
The breast journal,
M Yu Yukina, and
E A Troshina, and
D G Beltsevich
May 2015,
Lakartidningen,
M Yu Yukina, and
E A Troshina, and
D G Beltsevich
August 2014,
International journal of surgical pathology,
M Yu Yukina, and
E A Troshina, and
D G Beltsevich
June 1988,
The American journal of cardiology,
